Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other Accumulated Expenses (2020 - 2025)

Historic Other Accumulated Expenses for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $2.5 million.

  • Treace Medical Concepts' Other Accumulated Expenses fell 1756.62% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 1756.62%. This contributed to the annual value of $2.1 million for FY2024, which is 4823.77% down from last year.
  • Treace Medical Concepts' Other Accumulated Expenses amounted to $2.5 million in Q3 2025, which was down 1756.62% from $2.8 million recorded in Q2 2025.
  • Treace Medical Concepts' Other Accumulated Expenses' 5-year high stood at $4.5 million during Q1 2024, with a 5-year trough of $1.1 million in Q4 2021.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $2.9 million (2024), whereas its average is $2.9 million.
  • Per our database at Business Quant, Treace Medical Concepts' Other Accumulated Expenses surged by 14489.8% in 2021 and then crashed by 4823.77% in 2024.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Other Accumulated Expenses stood at $1.1 million in 2021, then soared by 64.63% to $1.8 million in 2022, then skyrocketed by 123.4% to $4.0 million in 2023, then crashed by 48.24% to $2.1 million in 2024, then grew by 22.57% to $2.5 million in 2025.
  • Its Other Accumulated Expenses stands at $2.5 million for Q3 2025, versus $2.8 million for Q2 2025 and $3.2 million for Q1 2025.